Safety Results of a Multi-Institutional Phase 1 Clinical Trial of Afatinib in Combination with Docetaxel and Postoperative Radiation Therapy for High-Risk Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Margalit, D. N. [1 ,2 ]
Haddad, R. I. [2 ]
Tishler, R. B. [1 ,2 ]
Chau, N. [3 ]
Schoenfeld, J. D. [1 ,2 ]
Bakst, R. L. [4 ]
Misiukiewicz, K. [4 ]
Goguen, L. [2 ,5 ]
Annino, D. [2 ,5 ]
Mchugh, P. [6 ]
Bacay, A.
Rath, L. [4 ]
Groden, P. [6 ]
Catalano, P. S. [7 ]
Rabinowits, G. [3 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[5] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Otolaryngol, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
95
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck A Randomized Clinical Trial
    Haddad, Robert
    Fayette, Jerome
    Teixeira, Maria
    Prabhash, Kumar
    Mesia, Ricard
    Kawecki, Andrzej
    Dechaphunkul, Arunee
    Dinis, Jose
    Guo, Ye
    Masuda, Muneyuki
    Hsieh, Ching-Yun
    Ghi, Maria Grazia
    Vaz de Melo Sette, Claudia
    Harrington, Kevin
    Tahara, Makoto
    Saba, Nabil F.
    Lau, Agnes
    Jiang, Tao
    Yan, Yibing
    Ballinger, Marcus
    Kaul, Monika
    Matheny, Christina
    Cuchelkar, Vaikunth
    Wong, Deborah J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [22] Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
    Harari, Paul M.
    Harris, Jonathan
    Kies, Merrill S.
    Myers, Jeffrey N.
    Jordan, Richard C.
    Gillison, Maura L.
    Foote, Robert L.
    Machtay, Mitchell
    Rotman, Marvin
    Khuntia, Deepak
    Straube, William
    Zhang, Qiang
    Ang, Kian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) : 2486 - U290
  • [23] A phase clinical trial of sorafenih in combination with eisplatin and docetaxel in patients with recurrent/metastatie squamous cell carcinoma of the head and neck (SCCHN).
    Savvides, Panayiotis
    Kumar, Pawan
    Gillison, Maura L.
    Teknos, Ted
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Phase II Randomized Trial of Postoperative Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)
    Kies, M. S.
    Harris, J.
    Rotman, M. Z.
    Myers, J. N.
    Foote, R. L.
    Machtay, M.
    Khuntia, D.
    Straube, W. L.
    Ang, K. K.
    Harari, P. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S14 - S15
  • [25] Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck
    Yao, Min
    Galanopoulos, Nicholas
    Lavertu, Pierre
    Fu, Pingfu
    Gibson, Michael
    Argiris, Athanassios
    Rezaee, Rod
    Zender, Chad
    Wasman, Jay
    Machtay, Mitchell
    Savvides, Panos
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (11): : 1665 - 1671
  • [26] A Phase II Trial of Chemoradiation Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients
    Zhu, G.
    Li, R.
    Dou, S.
    Zhong, L.
    Sun, J.
    Zhang, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S20 - S20
  • [27] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19): : 1937 - 1944
  • [28] Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck
    Tanvetyanon, Tawee
    Padhya, Tapan
    McCaffrey, Judith
    Kish, Julie A.
    Deconti, Ronald C.
    Trotti, Andy
    Rao, Nikhil G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06): : 840 - 845
  • [29] A Multi-institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated With Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Manyam, B.
    Garsa, A. A.
    Chin, R. I.
    Reddy, C. A.
    Gastman, B.
    Vidimos, A. T.
    Thorstad, W. L.
    Yom, S. S.
    Nussenbaum, B.
    Wang, S.
    Koyfman, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S159 - S160
  • [30] A Multi-institutional Comparison of Outcomes of Immunocompromised and Immunocompetent Patients Treated With Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Manyam, B.
    Garsa, A. A.
    Chin, R. I.
    Reddy, C. A.
    Gastman, B.
    Vidimos, A. T.
    Thorstad, W. L.
    Yom, S. S.
    Nussenbaum, B.
    Wang, S.
    Koyfman, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 948 - 948
12345